Moderna announced its decision to cease development of its vaccine mRNA-1647, which was being designed to treat birth defects ...

Less than 1 percent of clinical trials include pregnant or breastfeeding people. Experts say that needs to change ...

Moderna ends its CMV vaccine program after a Phase 3 trial failed to meet efficacy goals, but maintains its 2028 breakeven ...

Moderna stock toppled Thursday after the biotech company's experimental CMV vaccine failed in a Phase 3 study of 7,500 women.

Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital cytomegalovirus (CMV) infections – once ...

While development has been scrapped in CMV, a Phase II trial investigating the candidate in bone marrow transplant patients ...

Moderna said on Wednesday it would stop developing its experimental vaccine to prevent cytomegalovirus, a virus that can cause birth defects, after it failed to meet the main goal of a late-stage ...

Moderna had hoped its shot would be at least 49% effective at preventing CMV infections, substantially reducing the risk of ...

Heading into the winter respiratory virus season, Kaiser Permanente has begun offering a relatively new vaccine to certain expecting moms to help protect their newborns against respiratory syncytial ...

The health of mothers during pregnancy has long been known to play a role in the lifelong mental and physical health of offspring. Recent studies have found that contracting an infection during ...

'The pain was worse than labour pain. I thought my head was going to split, the mum said LIKE most people, when Happiness Temishe first developed a stuffy nose she brushed it off as allergies. The mum ...